6-KThe Wire
GENMAB A/S files 6-K
Filed Mar 30, 2026 · 3mo ago · Accession 0001434265-26-000052
Plain English
Genmab A/S announced on March 30, 2026, that it has entered into a definitive agreement to acquire all outstanding shares of Cytomx Therapeutics, Inc. for $30.00 per share in cash. This acquisition is expected to close in the second quarter of 2026, subject to customary closing conditions.
Filing details
- Company
- GENMAB A/S
- Ticker
- GMAB
- CIK
- 1434265
- Form type
- 6-K
- Filing date
- Mar 30, 2026
- Report date
- Mar 30, 2026
- Document
- gmab_2026330x6k.htm
- Size
- 598 KB